Exploring type I and III interferon signatures as predictive biomarkers for the clinical prognosis of dengue virus infection Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:13
G6PD DEFICIENCY AND THE REDOX IMBALANCE: NEW INSIGHTS INTO THE SUSCEPTIBILITY AND THE IMMUNE RESPONSE TO INFLUENZA A VIRUS Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:12
RNA aided immunotherapy of Epstein-Barr virus associated cancers: A novel approach for reconstitution of tumor immunogenicity in 3D microfluidic chips. Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:11
Characterization of interactions between Epstein-Barr Virus (EBV) and nuclear membrane during nuclear egress Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:11
Untangling the persistence of mixed cryoglobulinemia beyond hepatitis C virus Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:09
Ex vivo study on Type I and III interferon response and virus¿bacteria interactions in fibrosis cystic patients: a new approach to try to develop alternative therapeutic strategy Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:08
Bacterial/viral interactions in infection and immunity: application of the flow cytometry technology in different clinical settings Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:08
Human papillomavirus infection and related diseases: a multidisciplinary approach. Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 07:06
Manipolazione dell'autofagia e dell'effetto Warbourg come strategia per modificare il cross-talk tra cellule tumorali KSHV-associate e microambiente tumorale Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 06:55
A more accurate risk biomarkers recognition for Progressive Multifocal Leukoencephalopathy (PML) caused by JC virus in patients with multiple sclerosis during treatment with disease-modifying therapies (DMTs): an ongoing clinical challenge. Submitted by Anonimo (not verified) on Tue, 19/04/2022 - 06:49